Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products for the treatment of human disease. The company develops sotagliflozin, an orally-delivered small molecule drug for the treatment of hypertrophic...
235 insider purchases on record · latest filing 2026-02-25.
Insiders have also filed 6 sale transactions at LXRX.